Exero Medical closes on $12.7M preferred seed financing and establishes US presence to support clinical and commercial activities
JERSEY CITY, N.J., Feb. 13, 2025 /PRNewswire/ — Exero Medical, a US and Israel based company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7M in funding to complete its FDA pivotal…